14369-14-3 Usage
Description
6-Chloro-3-Methoxypyridazin-4-aMine is an organic compound characterized by its chloro and methoxy functional groups attached to a pyridazin-4-aMine scaffold. It is a versatile intermediate in the synthesis of various pyridazine derivatives, which are known for their diverse range of biological activities and applications in the pharmaceutical and chemical industries.
Uses
Used in Pharmaceutical Industry:
6-Chloro-3-Methoxypyridazin-4-aMine is used as a key intermediate for the synthesis of pyridazine derivatives, which are known to possess a wide range of pharmacological properties. These derivatives have been found to be effective in treating various diseases, including cancer, inflammation, and bacterial infections.
Used in Chemical Industry:
In the chemical industry, 6-Chloro-3-Methoxypyridazin-4-aMine serves as a valuable building block for the development of novel compounds with potential applications in various fields. Its unique structural features allow for further functionalization and modification, leading to the creation of new molecules with improved properties and performance.
Used in Research and Development:
6-Chloro-3-Methoxypyridazin-4-aMine is also utilized in research and development laboratories for the exploration of new synthetic routes and methodologies. Its reactivity and structural diversity make it an attractive candidate for the development of innovative chemical processes and the discovery of new compounds with potential applications in various industries.
Check Digit Verification of cas no
The CAS Registry Mumber 14369-14-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,4,3,6 and 9 respectively; the second part has 2 digits, 1 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 14369-14:
(7*1)+(6*4)+(5*3)+(4*6)+(3*9)+(2*1)+(1*4)=103
103 % 10 = 3
So 14369-14-3 is a valid CAS Registry Number.
14369-14-3Relevant articles and documents
TYK2 INHIBITORS AND USES THEREOF
-
Paragraph 00665, (2020/09/27)
Described herein are compounds that are useful in treating a TYK2-mediated disorder. In some embodiments, the TYK2-mediated disorder is an autoimmune disorder, an inflammatory disorder, a proliferative disorder, an endocrine disorder, a neurological disorder, or a disorder associated with transplantation.
A new route to aminodiazines via metalation reaction. Synthesis of an aza analogue of Nevirapine: Diazines XV
Plé, Nelly,Turck, Alain,Couture, Karine,Quéguiner, Guy
, p. 838 - 842 (2007/10/03)
A new route to aminodiazines is reported, the ortho-directed lithiation of diazines is used, followed by reaction with tosyl azide as an electrophile. The reduction of the azido or tetrazolo compounds obtained was achieved and led to the expected amines. This methodology has allowed the synthesis of new aminodiazines and an improvement in the yield of various aminodiazines previously described. This reaction was used for the preparation of an aza analogue of Nevirapine.
